MedTrace Logo

Miss Rate of Gastric Neoplasms Under Computer-aided Endoscopy

NCT06495645 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2025-11-20

No results posted yet for this study

Summary

This prospective randomized trial compares AI-assisted upper gastrointestinal endoscopy with high definition upper gastrointestinal endoscopy in term of missed rate of gastric neoplasm. The investigators hypothesize the miss rate of high definition upper gastrointestinal endoscopy is higher than AI-assisted upper gastrointestinal endoscopy.

Conditions

  • Gastric Neoplasm
  • Artificial Intelligence

Interventions

DEVICE

AI-assisted upper gastrointestinal endoscopy

AI-assisted upper gastrointestinal endoscopy

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Thomas Ka-Luen Lui · The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2026-09-01
Completion
2026-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06495645 on ClinicalTrials.gov